|
24/10/2012
|
Gilead Sciences announces third quarter 2012 financial results
Product sales of $2.36 billion, up 14 percent over third quarter of 2011; Antiviral product sales of $2.04 billion, up 13 percent over third quarter of 2011.
Read Gilead's 2011 Annual Report. |
|
-
News details








